Updated Jul 16, 2026
Edwards Carladenise Armbrister has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $230K.

Edwards Carladenise Armbrister is listed as a director of Clover Health Investments, Corp. (Delaware) in SEC filings as of May 19, 2026. Because corporate filings sometimes list names with different orders or with middle-name variations (for example Carladenise Edwards Armbrister or Edwards Armbrister Carladenise), there may be alternate form listings in public records. Public biographical information beyond the SEC filing context is not included here.
| Role | Director |
|---|---|
| Notability | 60/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-19 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | S — Open-market sale | 67.2K | $3.42 | $230K |
Edwards Carladenise Armbrister is listed as a director of Clover Health Investments, Corp. (Delaware) in SEC filings as of May 19, 2026. Because corporate filings sometimes list names with different orders or with middle-name variations (for example Carladenise Edwards Armbrister or Edwards Armbrister Carladenise), there may be alternate form listings in public records. Public …
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($230K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Edwards Carladenise Armbrister profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.